CrossrefInfokarte
P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling
Drug Metabolism and Disposition · 2026-04 · 54 (4) · 100254
DOI: 10.1016/j.dmd.2026.100254 ↗Abstract
Kein Abstract verfügbar.
EUVIMED